Check Your Claims Before Reviewers Do

 Quick Explanation Copied

 Long Explanation

Citation Impact & Career Profile

OpenAlex data shows 37 works, 5,654 citations, h-index 22 (OpenAlex, no DOI; openalex.org/A5079082089). The 1999 Science paper 'Bile Acids: Natural Ligands for an Orphan Nuclear Receptor' (Parks, ... Stimmel, Willson, Zavacki, Moore) accounts for 2,269 citations — ~40% of her lifetime total — a landmark in nuclear receptor biology (doi:10.1126/science.284.5418.1365). First-author work includes the 2000 JBC paper on site-specific cysteine conjugation of antibodies (doi:10.1074/jbc.m001672200, 72 citations) and 1998 chelation chemistry (doi:10.1016/s0969-8051(97)00151-0, 79 citations).

Critical Assessment

Her contribution pattern is characteristic of an expert industry scientist (GlaxoSmithKline nexus) enabling landmark discoveries rather than leading them: she is a middle author on most top-impact papers (FXR 1999; CAR/PXR 2000; PPARα corepressor structure 2002). The 2011 tocotrienol paper on which she is a corresponding technical contributor shows rigorous in vitro mechanistic work — PPAR-γ dependence, 15-LOX-2/15-S-HETE axis, TGF-β2/NF-κB downregulation — but is limited by high micromolar concentrations, absence of in vivo data, and only two cancer cell lines (doi:10.1016/j.freeradbiomed.2011.02.007). Publication output declines sharply after 2011, and no ORCID or institution is verifiable, limiting assessment of recent activity. First-authorship of an antibody-drug conjugation method that anticipated modern ADC site-specificity chemistry is a notable independent contribution.

 BGPT Author Review

Scientific Quality

Strong biochemical pedigree: co-author on the seminal FXR-bile-acid Science paper and multiple highly cited nuclear receptor papers, plus solid first-author mechanistic chemistry. H-index 22 is respectable but modest relative to the citation volume, reflecting heavy reliance on a few blockbuster co-authored papers rather than sustained first-author leadership.

Communication Quality

Papers are well-structured and mechanistically clear per available abstracts, but her public scientific communication footprint (reviews, talks, ORCID presence) is minimal, limiting direct assessment.

Author Novelty

Contributed to genuinely groundbreaking discoveries (orphan nuclear receptor deorphanization, FXR ligand identification) and early antibody site-specific conjugation chemistry that prefigured ADC technology.

Scientific Rigor

Work published in top journals (Science, Nature, JBC, PNAS) with detailed mechanistic controls (dominant-negative vectors, selective antagonists like GW9662, LC-MS/MS validation). Limitations: some studies relied on high supraphysiological concentrations and lacked in vivo validation.